A Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetics of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Subjects

Phase 1 Completed 18 enrolled CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

RandomizedCrossoverOpen-labelTreatment

Summary

This study is a single-dose, randomized, open-label, three-sequence, three-period crossover clinical trial to evaluate the effect of high-fat and low-fat meals on the pharmacokinetics of ammoxetine hydrochloride enteric-coated tablets in healthy subjects.

Timeline

Start: 2024-05-30
Primary completion: 2024-06-17
Completion: 2024-08-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ammoxetine	Unknown	60 mg	Oral

Indications

No indication recorded.